These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11303842)

  • 1. Ciprofloxacin-induced acute renal failure in a patient with cystic fibrosis.
    Bald M; Ratjen F; Nikolaizik W; Wingen AM
    Pediatr Infect Dis J; 2001 Mar; 20(3):320-1. PubMed ID: 11303842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciprofloxacin-induced renal insufficiency in cystic fibrosis.
    Moffett BS; Rosenstein BJ; Mogayzel PJ
    J Cyst Fibros; 2003 Sep; 2(3):152-4. PubMed ID: 15463865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations. The Cystic Fibrosis Study Group.
    Church DA; Kanga JF; Kuhn RJ; Rubio TT; Spohn WA; Stevens JC; Painter BG; Thurberg BE; Haverstock DC; Perroncel RY; Echols RM
    Pediatr Infect Dis J; 1997 Jan; 16(1):97-105; discussion 123-6. PubMed ID: 9002118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulopathy in two patients with cystic fibrosis treated with ciprofloxacin.
    Moore GC; Redfern J; Shiach CR; Webb K; Jones AM
    J Cyst Fibros; 2007 May; 6(3):209-11. PubMed ID: 17045852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy and safety of ciprofloxacin and ofloxacin in chronic Pseudomonas aeruginosa infection in cystic fibrosis.
    Jensen T; Pedersen SS; Nielsen CH; Høiby N; Koch C
    J Antimicrob Chemother; 1987 Oct; 20(4):585-94. PubMed ID: 3479420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoroquinolones in the treatment of cystic fibrosis: a critical appraisal.
    LeBel M
    Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):316-24. PubMed ID: 1907546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciprofloxacin as antipseudomonal treatment in patients with cystic fibrosis.
    Schaad UB; Wedgwood J; Ruedeberg A; Kraemer R; Hampel B
    Pediatr Infect Dis J; 1997 Jan; 16(1):106-11; discussion 123-6. PubMed ID: 9002119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. If you can't stand the rash, get out of the kitchen: an unusual adverse reaction to ciprofloxacin.
    Jaffé A; Bush A
    Pediatr Pulmonol; 1999 Dec; 28(6):449-50. PubMed ID: 10587421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rheumatologic aspects of pediatric cystic fibrosis patients treated with fluoroquinolones.
    Warren RW
    Pediatr Infect Dis J; 1997 Jan; 16(1):118-22; discussion 123-6. PubMed ID: 9002121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ciprofloxacin therapy in cystic fibrosis.
    Scully BE; Nakatomi M; Ores C; Davidson S; Neu HC
    Am J Med; 1987 Apr; 82(4A):196-201. PubMed ID: 3555036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ciprofloxacin monotherapy for acute pulmonary exacerbations of cystic fibrosis.
    Goldfarb J; Stern RC; Reed MD; Yamashita TS; Myers CM; Blumer JL
    Am J Med; 1987 Apr; 82(4A):174-9. PubMed ID: 3555032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What have we learned about early treatment of Pseudomonas aeruginosa infection in infants and children with cystic fibrosis?
    Saiman L; Cohen MB
    Arch Pediatr Adolesc Med; 2011 Sep; 165(9):867-8. PubMed ID: 21893653
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetic disposition of sequential intravenous/oral ciprofloxacin in pediatric cystic fibrosis patients with acute pulmonary exacerbation.
    Rubio TT; Miles MV; Lettieri JT; Kuhn RJ; Echols RM; Church DA
    Pediatr Infect Dis J; 1997 Jan; 16(1):112-7; discussion 123-6. PubMed ID: 9002120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ciprofloxacin safety in a pediatric population.
    Jick S
    Pediatr Infect Dis J; 1997 Jan; 16(1):130-3; discussion 133-4, 160-2. PubMed ID: 9002123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
    Cantón R; Cobos N; de Gracia J; Baquero F; Honorato J; Gartner S; Alvarez A; Salcedo A; Oliver A; García-Quetglas E;
    Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ciprofloxacin in the treatment of Pseudomonas infection in children with cystic fibrosis.
    Rubio TT
    Diagn Microbiol Infect Dis; 1990; 13(2):153-5. PubMed ID: 2114953
    [No Abstract]   [Full Text] [Related]  

  • 17. Arthropathy in a patient with cystic fibrosis taking ciprofloxacin.
    Alfaham M; Holt ME; Goodchild MC
    Br Med J (Clin Res Ed); 1987 Sep; 295(6600):699. PubMed ID: 3117310
    [No Abstract]   [Full Text] [Related]  

  • 18. Ciprofloxacin pharmacokinetics in young cystic fibrosis patients after repeated oral doses.
    Odoul F; Le Guellec C; Giraut C; de Gialluly C; Marchand S; Paintaud G; Saux MC; Rolland JC; Autret-Leca E
    Therapie; 2001; 56(5):519-24. PubMed ID: 11806288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ciprofloxacin overdose: acute renal failure with prominent apoptotic changes.
    Dharnidharka VR; Nadeau K; Cannon CL; Harris HW; Rosen S
    Am J Kidney Dis; 1998 Apr; 31(4):710-2. PubMed ID: 9531191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the new quinolones in cystic fibrosis.
    Grenier B
    Rev Infect Dis; 1989; 11 Suppl 5():S1245-52. PubMed ID: 2672252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.